Large serine recombinase-mediated gene insertion for high-throughput screens: advantages, design principles, and applications
Nucleic Acids Research · 2026
DOI: 10.1093/nar/gkag907 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nucleic Acids Research, 2026. Verfasst von Andrea Martella und 2 weiteren Autor:innen. Beteiligte Einrichtung: Discovery Sciences, R&D, Astra Zeneca, Cambridge, CB2 0AA, United Kingdom. Hauptthemen laut MEDLINE: DNA Nucleotidyltransferases, Mutagenesis, Insertional, High-Throughput Screening Assays, Recombinases. Die Arbeit nennt 166 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
High-throughput functional assays, such as multiplexed assays of variant effect (MAVE), increasingly demand stable, precise integration of large DNA libraries into mammalian genomes. While CRISPR-based technologies excel at localized, small-scale edits, they are constrained by payload size limits, heterogeneous editing outcomes, and, depending on the specific modality and repair pathway utilized, potential variability in junction fidelity during multikilobase insertions. In this review, we highlight large serine recombinases (LSRs) as highly efficient, single-enzyme alternatives for unidirectional, site-specific integration of large payloads with deterministic junctions. We survey targeted genomic integration strategies and detail best practices for implementing recombinase-based landing pad architectures. By enforcing single-copy, orientation-fixed integration at defined loci, landing pads decouple variant delivery from local chromatin effects to ensure the uniform, isogenic expression required for quantitative genotype–phenotype mapping. We further outline scalable applications of LSR-mediated integration across pooled and arrayed MAVE, CRISPR screens, and precise gene expression tuning. Finally, we assess current technological bottlenecks, particularly large donor delivery and the requisite pre-installation of canonical att recognition sites, while exploring emerging innovations in virus-like particle delivery, one-step CRISPR-recombinase systems, and computationally engineered programmable recombinases that promise to bypass these limitations and broaden mammalian genome engineering.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Discovery Sciences, R&D, Astra Zeneca, Cambridge, CB2 0AA, United Kingdom.
- Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, United States.
ORCID-Profile: Andrea Martella, David I Fisher
Zitieren
APA
Martella, A., Matreyek, K. A., & Fisher, D. I. (2026). Large serine recombinase-mediated gene insertion for high-throughput screens: advantages, design principles, and applications. Nucleic Acids Research. https://doi.org/10.1093/nar/gkag907
Vancouver
Martella A, Matreyek KA, Fisher DI. Large serine recombinase-mediated gene insertion for high-throughput screens: advantages, design principles, and applications. Nucleic Acids Research. 2026. doi:10.1093/nar/gkag907
BibTeX
@article{Martella2026,
author = {Martella, Andrea and Matreyek, Kenneth A and Fisher, David I},
title = {Large serine recombinase-mediated gene insertion for high-throughput screens: advantages, design principles, and applications},
journal = {Nucleic Acids Research},
year = {2026},
doi = {10.1093/nar/gkag907}
}
EUVIMED